Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

AGM Results

30 May 2012 11:36

RNS Number : 4067E
Microsaic Systems plc
30 May 2012
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

AGM Results, Completion of Placing, Board and Committee Changes

 

30 May 2012

 

Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, announces that its Annual General Meeting ("AGM") was held at 11.00 a.m. (UK time) this morning and that all resolutions were duly passed.

 

Following the announcement on 29 May and the passing of the resolutions at the AGM, the Company is also pleased to announce that the conditional placing ("Placing") of 3,867,248 new ordinary shares of 0.25p each ("Placing Shares") at a price of 40 pence per Placing Share, raising approximately £1.55 million (before expenses), has been completed subject to admission of the Placing Shares (expected on 1 June 2012) becoming effective in accordance with the AIM Rules for Companies. The net proceeds of the Placing will be deployed to further the growth plans of the Company.

 

Non-executive director Peter Selway formally retired from Microsaic's board of directors at the AGM. Mr Selway's intention to retire during the current financial year was noted in the Company's preliminary results for the full year ending 31 December 2012.

 

As a result of Mr Selway's retirement, non-executive director Andrew Holmes has been appointed to the audit and remuneration committees of the Company's board of directors. The audit committee is chaired by Colin Nicholl and also comprises James Ramage and Andrew Holmes. The remuneration committee is now chaired by James Ramage and also comprises Colin Nicholl and Andrew Holmes.

 

Colin Nicholl, commented:

 

"Peter has planned for some time to retire upon reaching the age of 70 in 2012. The board is most grateful for his wise council and distinguished service over the last 11 years, and we all wish him well and a long and happy retirement."

 

Enquiries:

 

Microsaic Systems plc

via Citigate Dewe Rogerson

Eric Yeatman, CEO

Colin Nicholl, Chairman

Numis Securities Limited

+44 (0)20 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

Citigate Dewe Rogerson (Financial PR)

+44 (0)20 7638 9571

Chris Gardner, Mark Swallow, Malcolm Robertson

The Scott Partnership (Trade PR)

+44 (0)1477 539540

Sarah Evans

 

 

About Microsaic Systems plc

Microsaic Systems develops chip-based scientific instruments for the identification of substances in solids, liquids and gases. The Company's products are based on the 'gold-standard' scientific technique of mass spectrometry (MS).

Microsaic Systems has developed a miniaturised mass spectrometer product, based on its patented, chip-based technologies (ionchip®, spraychip® and vac-chip™), that is smaller, lighter, quieter, more energy efficient and cheaper to run than conventional MS systems.

Mass spectrometry (MS) is used across multiple sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3.3 billion in 2010.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMWGUAWAUPPGUU
Date   Source Headline
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20212:13 pmRNSHolding(s) in Company
16th Feb 20219:00 amRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSFramework Services Agreement
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20215:59 pmRNSHolding(s) in Company
8th Feb 20215:58 pmRNSHolding(s) in Company
8th Feb 202111:08 amRNSHolding(s) in Company
8th Feb 202111:06 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
5th Feb 20215:02 pmRNSHolding(s) in Company
5th Feb 20213:22 pmRNSHolding(s) in Company
5th Feb 20218:05 amRNSDirector/PDMR Shareholding
5th Feb 20218:01 amRNSBoard Changes
4th Feb 202110:22 amRNSResult of General Meeting
29th Jan 20212:05 pmRNSSecond Price Monitoring Extn
29th Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Jan 20215:26 pmRNSFull Exercise of Broker Option
19th Jan 20212:06 pmRNSSecond Price Monitoring Extn
19th Jan 20212:00 pmRNSPrice Monitoring Extension
19th Jan 202111:05 amRNSSecond Price Monitoring Extn
19th Jan 202111:00 amRNSPrice Monitoring Extension
19th Jan 20219:05 amRNSSecond Price Monitoring Extn
19th Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSFundraising, Board Changes and Notice of GM
6th Jan 20214:41 pmRNSSecond Price Monitoring Extn
6th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSStatement re. share price movement
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.